Literature DB >> 25548062

Risk of early recurrent stroke in symptomatic carotid stenosis.

S Strömberg1, A Nordanstig2, T Bentzel3, K Österberg4, G M L Bergström3.   

Abstract

OBJECTIVES: The risk of recurrent stroke in patients with symptomatic carotid artery stenosis is highest in the first weeks after a transient ischemic attack (TIA) or minor stroke and can be reduced with carotid endarterectomy (CEA). The optimal timing of CEA remains a controversial issue since very urgent CEA is associated with an increased procedural risk. The aim of this study was to determine the risk of very early recurrent stroke in a population with symptomatic high grade carotid stenosis.
METHODS: Data were analyzed on all patients with ocular TIA, TIA, or minor stroke with >70% carotid stenosis as assessed by carotid ultrasound at Sahlgrenska University Hospital during the periods 2004-2006 and 2010-2012. The two time periods were chosen to minimize selection bias and to analyze changes over time. The risk of recurrent stroke within 30 days of the referring event was assessed.
RESULTS: 397 patients with symptomatic carotid stenosis were identified. The risk of recurrent stroke in the total cohort was 2.0% (CI 95% 0.6-3.4) by day 2, 4.0% (CI 95% 2.0-5.9) by day 7, and 7.5% (CI 95% 4.4-10.6) by day 30. There was no significant difference between the two time periods. Patients with minor stroke had a significantly higher risk of recurrent stroke than patients with TIA or ocular TIA as the referring event.
CONCLUSIONS: The data suggest that the early risk of recurrent stroke in symptomatic significant carotid stenosis is not as high as some earlier studies have shown. The risk is similar to several studies in which a modern medical treatment regime could be assumed.
Copyright © 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carotid disease; Carotid stenosis; Stroke; Transient ischemic attack

Mesh:

Year:  2014        PMID: 25548062     DOI: 10.1016/j.ejvs.2014.11.004

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  Ischemic Stroke Patients Demonstrate Increased Carotid Plaque Microvasculature Compared to (Ocular) Transient Ischemic Attack Patients.

Authors:  Raf H M van Hoof; Floris H B M Schreuder; Patty Nelemans; Martine T B Truijman; Narender P van Orshoven; Tobien H Schreuder; Werner H Mess; Sylvia Heeneman; Robert J van Oostenbrugge; Joachim E Wildberger; M Eline Kooi
Journal:  Cerebrovasc Dis       Date:  2017-09-26       Impact factor: 2.762

2.  Amaurosis fugax - delay between symptoms and surgery by specialty.

Authors:  Pia Kvickström; Bertil Lindblom; Göran Bergström; Madeleine Zetterberg
Journal:  Clin Ophthalmol       Date:  2016-11-17

3.  Increased Vascularization in the Vulnerable Upstream Regions of Both Early and Advanced Human Carotid Atherosclerosis.

Authors:  Ola Hjelmgren; Karl Gellerman; Josefin Kjelldahl; Per Lindahl; Göran M L Bergström
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

Review 4.  Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases.

Authors:  Ning Li; Heng Zhou; Qizhu Tang
Journal:  Dis Markers       Date:  2017-09-06       Impact factor: 3.434

5.  COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis.

Authors:  Joakim Sandstedt; Karin Vargmar; Kristina Björkman; Ulla Ruetschi; Göran Bergström; Lillemor Mattsson Hultén; Eva Skiöldebrand
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 8.311

6.  Amaurosis fugax: risk factors and prevalence of significant carotid stenosis.

Authors:  Pia Kvickström; Bertil Lindblom; Göran Bergström; Madeleine Zetterberg
Journal:  Clin Ophthalmol       Date:  2016-10-31

Review 7.  Timing of carotid endarterectomy and clinical outcomes.

Authors:  Bilal Azhar; Arsalan Wafi; James Budge; Ian Loftus
Journal:  Ann Transl Med       Date:  2020-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.